VT recurrence after ablation: incomplete ablation or disease progression? A multicentric European study
Identifikátory výsledku
Kód výsledku v IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00023001%3A_____%2F16%3A00059757" target="_blank" >RIV/00023001:_____/16:00059757 - isvavai.cz</a>
Výsledek na webu
<a href="http://dx.doi.org/10.1111/jce.12858" target="_blank" >http://dx.doi.org/10.1111/jce.12858</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.1111/jce.12858" target="_blank" >10.1111/jce.12858</a>
Alternativní jazyky
Jazyk výsledku
angličtina
Název v původním jazyce
VT recurrence after ablation: incomplete ablation or disease progression? A multicentric European study
Popis výsledku v původním jazyce
NICM VT Ablation AimTo determine whether ventricular tachycardia (VT) recurrences in arrhythmogenic RV cardiomyopathy (ARVC) and nonischemic cardiomyopathy (NICM) are related to incomplete ablation or disease progression. MethodsARVC and NICM patients with two substrate maps of the same diseased ventricle with an interprocedural delay of 12 months were included. Disease progression was defined as 1 factor: scar area progression (PROG, +5%), ventricular remodeling (dilatation [+25 mL] or decreased ejection fraction [-5%EF]). Incomplete ablation was defined as index VT recurrence or ablation in previously unablated regions inside index scar without PROG. ResultsTwenty patients from nine centers were included (80% male 55 16years, 7 ARVC and 13 NICM, LVEF 43 +/- 14%). Mean delay was 28 +/- 18 months. Disease progression occurred in 75% with ventricular remodeling in 70%: ventricular dilation in 45% (ARVC [71%]; NICM [38%]), decreased EF in 60% [RVEF in ARVC (71%); LVEF in NICM (54%)], and scar progression in 50% (in ARVC [57%] and NICM [46%]). Index VT recurrence was observed in 40%. Redo ablation sites were located in previously unablated regions inside the index scar in 70% of patients. VT recurrence following the second procedure was seen in 25%. Fifteen percent died during a follow-up of 17 +/- 17 months. ConclusionDisease progression is the rule in ARVC and NICM while scar progression occurs in half. However, even if disease progression is frequently observed, incomplete index ablation is the most common finding, strongly suggesting the need for more extensive ablation.
Název v anglickém jazyce
VT recurrence after ablation: incomplete ablation or disease progression? A multicentric European study
Popis výsledku anglicky
NICM VT Ablation AimTo determine whether ventricular tachycardia (VT) recurrences in arrhythmogenic RV cardiomyopathy (ARVC) and nonischemic cardiomyopathy (NICM) are related to incomplete ablation or disease progression. MethodsARVC and NICM patients with two substrate maps of the same diseased ventricle with an interprocedural delay of 12 months were included. Disease progression was defined as 1 factor: scar area progression (PROG, +5%), ventricular remodeling (dilatation [+25 mL] or decreased ejection fraction [-5%EF]). Incomplete ablation was defined as index VT recurrence or ablation in previously unablated regions inside index scar without PROG. ResultsTwenty patients from nine centers were included (80% male 55 16years, 7 ARVC and 13 NICM, LVEF 43 +/- 14%). Mean delay was 28 +/- 18 months. Disease progression occurred in 75% with ventricular remodeling in 70%: ventricular dilation in 45% (ARVC [71%]; NICM [38%]), decreased EF in 60% [RVEF in ARVC (71%); LVEF in NICM (54%)], and scar progression in 50% (in ARVC [57%] and NICM [46%]). Index VT recurrence was observed in 40%. Redo ablation sites were located in previously unablated regions inside the index scar in 70% of patients. VT recurrence following the second procedure was seen in 25%. Fifteen percent died during a follow-up of 17 +/- 17 months. ConclusionDisease progression is the rule in ARVC and NICM while scar progression occurs in half. However, even if disease progression is frequently observed, incomplete index ablation is the most common finding, strongly suggesting the need for more extensive ablation.
Klasifikace
Druh
J<sub>x</sub> - Nezařazeno - Článek v odborném periodiku (Jimp, Jsc a Jost)
CEP obor
FA - Kardiovaskulární nemoci včetně kardiochirurgie
OECD FORD obor
—
Návaznosti výsledku
Projekt
—
Návaznosti
N - Vyzkumna aktivita podporovana z neverejnych zdroju
Ostatní
Rok uplatnění
2016
Kód důvěrnosti údajů
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Údaje specifické pro druh výsledku
Název periodika
Journal of cardiovascular electrophysiology
ISSN
1045-3873
e-ISSN
—
Svazek periodika
27
Číslo periodika v rámci svazku
1
Stát vydavatele periodika
GB - Spojené království Velké Británie a Severního Irska
Počet stran výsledku
8
Strana od-do
80-87
Kód UT WoS článku
000368017000011
EID výsledku v databázi Scopus
—